Goldman Sachs Adjusts Houlihan Lokey’s Price Target Amid Banking Pressures

Houlihan Lokey Inc.’s stocks have been trading up by 4.3 percent driven by strong quarterly earnings forecasts.

Key Takeaways

Goldman Sachs has revised its price target for Houlihan Lokey, reducing it from $243 to $210. Despite this adjustment, they continue to recommend a Buy rating, indicating long-term confidence in the firm’s prospects.
The change comes amidst an environment of moderate investment banking volumes, which, while still increasing, are experiencing a deceleration.
Current pressures on bank valuations are partly triggering these revisions, yet the merger and acquisition (M&A) cycle is perceived to still be in its mid-stage with solid long-term potential.
Investors should note the underlying market dynamics as the global banking sector navigates valuation challenges, yet opportunities in the M&A cycle are anticipated to provide support for future performance.
Houlihan Lokey’s strategic positioning amidst these external pressures remains a pivotal factor in its sustained Buy rating according to Goldman Sachs.

Weekly Update Mar 16 – Mar 20, 2026: On Saturday, March 21, 2026 Houlihan Lokey Inc. stock [NYSE: HLI] is trending up by 4.3%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Finance industry expert:

Analyst sentiment – positive

More Breaking News

Market Position & Fundamentals: Houlihan Lokey (HLI) demonstrates strong financial fundamentals reflected in its solid profitability metrics, notably a high pre-tax profit margin of 22.5% and a consistent profit margin of 17.22%. The company’s revenue growth over the past three and five-year periods is healthy at 12.58% and 14.39% respectively, signaling robust performance in capturing market opportunities. With a relatively low total debt-to-equity ratio of 0.22, HLI maintains a strong balance sheet position, although the negative EBIT margin suggests some cost inefficiencies potentially affecting operational capacity. The intrinsic value remains attractive with a price-to-earnings ratio of 21.31 and a price-to-book ratio of 4.23, indicating potential undervaluation in relation to its earnings capability.
Technical Analysis & Trading Strategy: Analyzing the weekly price pattern, Houlihan Lokey’s shares have experienced a slight upward trend. Starting the week at an open of 139.51, the stock exhibited resilience despite initial volatility, closing the week at 144.92. This uptrend is confirmed by the 5-minute candle analysis showing consistent buying pressure. The close at the high of the week suggests strong bullish momentum. The volume patterns indicate heightened investor interest, pointing towards a robust demand zone around the 140 level. Traders should consider a buy strategy on pullbacks towards 140 with a stop loss placed just below the 137.75 support level, targeting an upside potential towards 150.
Catalysts & Outlook: According to recent analysis by Goldman Sachs, which revised Houlihan Lokey’s price target from $243 to $210 yet remains optimistic with a Buy rating, the firm is well-positioned amidst a moderating investment banking environment. As the M&A cycle is viewed at a mid-stage, the long-term demand for advisory services remains solid, providing a tailwind to HLI’s prospects. Despite recent pressure on bank valuations, HLI, with its specialization in advisory, contrasts positively against broader financial benchmarks. Support levels remain firm around 210, with medium-term resistance expected at 243. Given the industry position and financial solidity, the outlook for HLI remains favorable.

Quick Financial Overview

Houlihan Lokey Inc. (HLI) exhibits a blend of resilient financial metrics and strategic growth avenues. With a revenue of approximately $2.31B and a substantial EBITDA margin indicating negligible values, the company reflects a peculiar profitability pathway. The pre-tax profit margin stands robustly at 22.5%, while the net income tallies to $116.55M. Notably, with a price-to-sales ratio of 3.73 and a firm price-to-book ratio of 4.23, HLI demonstrates a balanced valuation approach amidst market challenges.

In the latest quarter, HLI’s operations yielded an operating cash flow of $217.68M, underscoring robust liquidity management. Interestingly, stock buybacks and dividends remain integral, as highlighted by a dividend rate of $2.4 coupled with common stock payments manifesting stringent capital discipline.

Moving to the technical chart analysis, HLI’s stock oscillated between $137.75 and $144.92 recently, displaying a price stability across different trading sessions. Despite some dips, the stock closed staunchly at a higher point, suggesting continued investor interest and potential upward momentum. The swift rise on March 20, 2026 to $144.92 indicates possible investor optimism in light of potential positive developments within the firm and industry.

Conclusion

Amidst prevailing market complexities, Houlihan Lokey manages to maintain a balanced outlook. While facing valuation pressures akin to its peers, the firm’s intrinsic strengths remain its capability to exploit M&A opportunities. As Goldman Sachs’ report reflects, the stock’s long-term prospects remain optimistic at its current price levels.

Traders should anticipate nuanced movements in HLI’s stock as strategic forecasts materialize. As Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.” This quote encapsulates the importance of strategic readiness in trading, particularly as the combination of current banking pressures and future growth potential positions Houlihan Lokey at an intersection of caution and opportunity. As HLI navigates these waters, astute recipients of these developments could find lucrative trading pathways.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!